Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Tumor-Specific CD8(+) T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
  2. Kerkar, S. P.; Muranski, P.; Kaiser, A.; Boni, A.; Sanchez-Perez, L.; Yu, Z. Y.; Palmer, D. C.; Reger, R. N.; Borman, Z. A.; Zhang, L.; Morgan, R. A.; Gattinoni, L.; Rosenberg, S. A.; Trinchieri, G.; Restifo, N. P.
  3. Cancer Research. 2010, Sep; 70(17): 6725-6734.
  1. 2.   In vivo hydrodynamic delivery of cDNA encoding IL-2: Rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells
  2. Ortaldo, J. R.; Winkler-Pickett, R. T.; Bere, E. W.; Watanabe, M.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2005, JUL 15; 175(2): 693-699.
  1. 3.   Caulibugulones A-F, novel cytotoxic isoquinoline quinones and iminoquinones from the marine bryozoan Caulibugula intermis
  2. Milanowski, D. J.; Gustafson, K. R.; Kelley, J. A.; McMahon, J. B.
  3. Journal of Natural Products. 2004 67(1): 70-73.
  1. 4.   Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker
  2. Marquez, V. E.; Ben Kasus, T.; Barchi, J. J.; Green, K. M.; Nicklaus, M. C.; Agbaria, R.
  3. Journal of the American Chemical Society. 2004 126(2): 543-549.
  1. 5.   Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studies
  2. Winter, H.; Hu, H. M.; Poehlein, C. H.; Huntzicker, E.; Osterholzer, J. J.; Bashy, J.; Lashley, D.; Lowe, B.; Yamada, J.; Alvord, G.; Urba, W. J.; Fox, B. A.
  3. Immunology. 2003 108(3): 409-419.
  1. 6.   TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells
  2. Poehlein, C. H.; Hu, H. M.; Yamada, J.; Assmann, K.; Alvord, W. G.; Urba, W. J.; Fox, B. A.
  3. Journal of Immunology. 2003 170(4): 2004-2013.
  1. 7.   Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice
  2. Papadopoulou, M. V.; Ji, M.; Ji, X. H.; Bloomer, W. D.; Hollingshead, M. G.
  3. Cancer Chemotherapy and Pharmacology. 2002 50(6): 501-508.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel